Latest news with #Cardiology
Globe and Mail
5 days ago
- Health
- Globe and Mail
Stethoscope Market to Reach USD 826.84 Million by 2030, Driven by Demand for Electronic Devices and Smart Diagnostics
Mordor Intelligence has published a new report on the Stethoscope Market offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction According to a 2025 report on Stethoscope Market by Mordor Intelligence, the global market is projected to grow from USD 663.5 million in 2025 to USD 826.84 million by 2030, registering a CAGR of 4.5% during the forecast period. The report highlights the rising adoption of electronic stethoscopes, along with expanding telemedicine practices and increasing emphasis on digital healthcare infrastructure, as key factors supporting market growth. The stethoscope remains one of the most essential tools in medical diagnostics, widely used by healthcare professionals across the world. From primary care physicians to specialists in cardiology and pulmonology, stethoscopes are vital for auscultating internal body sounds such as heartbeats, lung function, and bowel activity. Over the years, Stethoscope market has expanded beyond traditional acoustic devices to include electronic and smart stethoscopes that offer enhanced sound amplification, noise filtering, and digital recording Market Trends Rising Adoption of Electronic Stethoscopes: Healthcare professionals are increasingly shifting to electronic stethoscopes for their ability to amplify sounds, reduce ambient noise, and provide more accurate diagnostics. Integration with Telemedicine Platforms: Smart and digital stethoscopes are being used in remote consultations, allowing physicians to perform auscultations virtually by transmitting high-fidelity audio data. Growing Focus on Chronic Disease Monitoring: With the rising prevalence of cardiovascular and respiratory conditions, stethoscopes remain a key diagnostic tool, especially in routine monitoring and early-stage detection. Increased Demand from Home Healthcare Settings: The home healthcare segment is witnessing higher usage of user-friendly and connected stethoscopes, particularly for patients managing long-term illnesses at home. Market Segmentation By Type Acoustic / Manual Stethoscopes: Traditional and widely used, these stethoscopes rely on sound transmission through hollow tubes and remain the go-to choice for many general practitioners. Electronic Stethoscopes: These offer sound amplification and noise cancellation, making them suitable for environments where accurate auscultation is critical, such as emergency and cardiology departments. Smart / AI-Enabled Stethoscopes: Equipped with digital sensors and connectivity features, these devices can record, store, and analyze auscultation data, often integrated with telemedicine platforms. Teaching & Training Stethoscopes: Designed with dual-headpieces or recording capabilities, these are used in academic settings to train medical students and professionals in diagnostic skills. Veterinary Stethoscopes: Tailored for animal physiology, these are used in veterinary clinics and practices to monitor heart, lung, and other internal sounds in pets and livestock. By End User Hospitals & Clinics: These settings represent the largest share of usage, with stethoscopes being essential tools for daily physical exams, diagnostics, and monitoring. Ambulatory Surgical Centers: Used during preoperative and postoperative assessments; stethoscopes support quick evaluations in these outpatient surgical facilities. Home Healthcare: With the growth of in-home care, especially for elderly and chronically ill patients, stethoscopes are increasingly used by nurses and caregivers for routine checks. Telehealth Providers: Digital and smart stethoscopes are facilitating remote auscultation, supporting virtual consultations and expanding care access. Veterinary Practices: Used by veterinarians for diagnostic evaluations across a range of animal species, particularly in specialized or large-animal care. Academic & Training Institutions: Medical schools and training centers utilize stethoscopes to teach diagnostic techniques and clinical practices to students. By Geography North America: A mature market driven by early adoption of electronic devices and integration with digital health systems. Europe: Maintains strong demand with a well-established healthcare system and growing use of smart medical devices. Asia Pacific: The fastest-growing region due to expanding healthcare infrastructure, rising patient population, and increased device adoption. Middle East: A developing market showing steady growth as healthcare facilities modernize and adopt new diagnostic technologies. Major Players 3M Known for its Littmann brand, 3M is a global leader in stethoscope manufacturing, offering a wide range of high-quality acoustic and electronic models widely used by healthcare professionals worldwide. GF Health Products, Inc. Also known as Graham-Field, the company supplies a variety of medical equipment, including stethoscopes, catering to both clinical and home healthcare markets with cost-effective diagnostic tools. American Diagnostic Corporation (ADC) ADC specializes in diagnostic instruments and is recognized for its durable and reliable stethoscopes, designed for use across hospitals, clinics, and academic institutions. ICU Medical, Inc. Though primarily focused on infusion systems and IV therapy, ICU Medical also operates in diagnostic equipment and continues to support clinical use through its healthcare solutions. Baxter (Hill-Rom) Through its Hill-Rom brand, Baxter provides electronic and smart stethoscopes integrated with digital features, supporting the demand for connected care and telehealth-compatible devices. Conclusion The stethoscope market continues to hold a crucial place in medical diagnostics, with consistent demand across hospitals, clinics, academic institutions, and emerging telehealth services. While acoustic stethoscopes remain widely used due to their reliability and affordability, there is a visible shift toward electronic and smart variants that offer enhanced sound quality, digital recording, and remote connectivity. This shift is aligned with the growing need for precision diagnostics, especially in chronic disease management and virtual consultations. Industry Related Reports Electronic Stethoscope Market : The Electronic Stethoscope Market report is segmented by Product (Amplified Electronic Stethoscopes and Digital Electronic Stethoscopes), by Technology (Integrated Chest-Piece System, Wireless Transmission System, and others), by End User (Hospitals and Clinics, Ambulatory Surgery Centers, and more), by Connectivity (Wired, Bluetooth, Wi-Fi), by Distribution Channel (Offline Retail & Distributors, and others), and by Geography. Pocket Otoscope Market: The market is segmented by Application, by End User (Hospitals, ENT Clinics, and Others), and by Geography. Europe Telehealth Service Market : The Europe Telehealth Service Market report segments the industry by Service Type (Telemedicine, Video Conferencing, Remote Patient Monitoring, App-Based Consultation, and Others), by Application Type (Tele-consultation, Tele-pathology, Patient Care, and more), by End Users (Providers, Patients, and more), by Category (Hardware, Software), by Delivery Mode, and by Geography. About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries or to access the full report, please contact:media@
Yahoo
16-07-2025
- Business
- Yahoo
NextGen Healthcare Chosen by Phoenix Heart to Optimize Financial Outcomes and Enhance Patient Experience
Large Arizona Cardiology Group to Boost Clinical, Operational, and Financial Efficiency with Specialty-Specific HealthTech REMOTE-FIRST COMPANY/PHOENIX, July 16, 2025--(BUSINESS WIRE)--NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, has been selected by Phoenix Heart to improve workflows, deliver meaningful financial and operational analytics, and enable a better experience for patients, providers and staff. The NextGen Cardiology Suite, a specialty package that overlays the NextGen® Enterprise EHR (electronic health record), will reduce friction by supporting specialty-specific workflows. Voted the state's #1 cardiology group for eight consecutive years in the annual The Best in Arizona Business poll, Phoenix Heart offers heart, vein, and vascular care across eight locations in the greater Phoenix region. Until now, staff at Phoenix Heart have relied on tedious manual processes to complete mission-critical workflows. NextGen® Enterprise PM (practice management), NextGen® Financial Analytics and NextGen® Operational Analytics will be integrated to simplify workflows while offering transparency, predictive analytics, and actionable insights. "NextGen Healthcare understands our needs and shares our commitment to making healthcare as seamless as possible for providers, staff, and the communities we serve," said Elizabeth Saylor, chief executive officer, Phoenix Heart. "We're excited to work together to improve clinical, operational, and financial processes and continue raising the bar in cardiovascular care." NextGen® Patient Engage powered by Luma will boost staff efficiency by equipping patients to complete pre-visit intake at their own convenience from their personal devices. The Instant Medical History enhancement will capture discrete data from patients during remote check-in and seamlessly deliver that information to the appropriate places in the system. NextGen® Automated Document Sharing will also automate outbound faxes and expedite the delivery of documents into patient portals—minimizing work for staff and making it easier for patients to quickly access information. "Phoenix Heart has been leading the way in cardiovascular care in Arizona for over four decades," said Srinivas (Sri) Velamoor, president and chief operating officer, NextGen Healthcare. "We are privileged to support Phoenix Heart with the next stage of their growth journey and elevate the provider, staff, and patient experiences with specialty-specific solutions that reduce burdens and make healthcare delivery more intuitive." To learn more about how NextGen Healthcare helps cardiology practices achieve their goals, visit About Phoenix Heart Voted No. 1 in cardiology groups by Ranking Arizona magazine's Best in AZ Businesses readers' poll, Phoenix Heart is the leading cardiology group in the greater Phoenix area. Phoenix Heart has eight offices, conveniently located in Glendale, Scottsdale, Avondale, Anthem, Black Canyon City, Buckeye, Cottonwood, and Laveen Village. Since its inception in 1981, Phoenix Heart has set the gold standard for cardiological care in Arizona and beyond. The cardiologists that make up the medical team at Phoenix Heart represent an incredibly diverse and elite background of training, skills, and specialties. They're committed to improving and enriching the lives and health of every patient they see and are consistently at the forefront of adopting the newest and best technologies to advance the health of their patients. About NextGen Healthcare NextGen Healthcare, Inc. is a leading provider of innovative healthcare technology and data solutions. We are reimagining ambulatory healthcare with award-winning EHR, practice management and surround solutions that enable providers to deliver whole-person health and value-based care. Our highly integrated, intelligent, and interoperable solutions increase clinical quality and productivity, enrich the patient experience and drive superior financial performance. We are on a relentless quest to achieve better healthcare outcomes for all. Learn more at and follow us on Facebook, X, LinkedIn, YouTube, and Instagram. View source version on Contacts Anjali Bright(731) 234-6422Abright@ Sign in to access your portfolio
Globe and Mail
24-06-2025
- Business
- Globe and Mail
BSX Raises 2025 Financial Outlook: What's Backing It?
Boston Scientific BSX has raised its full-year 2025 guidance following robust first-quarter results and continued momentum across key growth areas. The company now anticipates net sales to grow approximately 15-17% on a reported basis (earlier 12.5-14.5%) and nearly 12-14% on an organic basis (earlier 10-12%). Full-year adjusted earnings per share are expected to be in the range of $2.87-$2.94 (previously $2.80-$2.87). On the flip side, the company expects a $200 million tariff impact in 2025, mainly in the second half. In the first quarter, the company delivered organic sales growth of 18%, exceeding the guided range of 14-16%. Adjusted EPS was $0.75, marking a 34% year-over-year increase and surpassing the forecasted $0.66-$0.68 range. This growth reflects the durability of BSX's category leadership strategy, which is powered through meaningful innovation and clinical evidence generation. Boston Scientific's Cardiology segment sales surged 31%, driven by robust growth in products such as WATCHMAN, AGENT drug-coated balloon (DCB) and FARAPULSE. WATCHMAN gained market share through rising concomitant procedures. In addition, its Electrophysiology ('EP') business experienced robust growth, with sales up 145% year over year. This has positioned BSX as the second-largest player globally, largely due to the rapid adoption of pulsed field ablation (PFA) with FARAPULSE. Geographically, sales in the United States rose 31%, while Asia-Pacific and EMEA regions delivered 11% and 8% sales growth, respectively. Asia-Pacific growth was led by double-digit growth in Japan and high single-digit growth in China (despite volume-based procurement headwinds). BSX also plans to successfully offset the tariff impact through full-year organic sales guidance raise, targeted discretionary spending reductions and a $0.01FX benefit. Boston Scientific's Competitors Edwards Lifesciences EW reiterated its 2025 sales growth forecast of 8-10% but raised the sales dollar guidance range by $100 million, reaching $5.7-$6.1 billion. The revision was made to account for the recent movement in foreign exchange rates. Edwards continues to expect 2025 adjusted EPS to be in the range of $2.40-$2.50 despite headwinds from tariffs. This growth trajectory is driven by the continued global adoption of SAPIEN 3 Ultra RESILIA, PASCAL and EVOQUE systems. Stryker SYK raised its sales guidance for 2025, led by strong first-quarter performance, continued capital demand and robust commercial execution. The company now expects total revenues to grow in the range of 8.5-9.5% on an organic basis (previously 8-9%). However, SYK lowered its EPS guidance to $13.20-$13.45 from $13.45-$13.70, reflecting headwinds from the Inari Medical acquisition and a $200 million impact from announced tariffs. BSX Stock Price Performance, Valuation and Estimate Trend Shares of Boston Scientific have gained 33.4% in the past year compared with the industry's growth of 8.8%. The S&P 500 composite has grown 9.3% in the same period. Image Source: Zacks Investment Research From a valuation standpoint, BSX trades at a forward 12-month price-to-earnings ratio (P/E) of 33.19X, above the industry's 20.83X. The Zacks Consensus Estimate for BSX's earnings has been on the rise over the past 60 days. BSX stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks Names #1 Semiconductor Stock It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX): Free Stock Analysis Report Stryker Corporation (SYK): Free Stock Analysis Report Edwards Lifesciences Corporation (EW): Free Stock Analysis Report
Zawya
06-06-2025
- Health
- Zawya
Liberia: Ambassador Yin Chengwu Attends Handover Ceremony of Cardiology Department Project Under Paired Hospital Cooperation Mechanism
On June 3, Chinese Ambassador to Liberia Yin Chengwu attended the handover ceremony of the Cardiology Department project under the China-Liberia Paired Hospital Cooperation Mechanism. Also present were Liberian Health Minister Hon. Dr. Louise M. Kpoto, JFK Medical Center Chief Executive Officer Dr. Linda Birch, representatives from Heilongjiang Provincial Hospital, members of the 17th Chinese Medical Team to Liberia, and representatives from JFK Medical Center, totaling about 100 attendees. Minister Dr. Louise Kpoto and CEO Dr. Linda Birch expressed gratitude to the Chinese government for its long-term and strong support to Liberia's health sector. They stated that this project, as Liberia's first dedicated cardiology diagnosis and treatment department, would surely provide higher quality medical services to the people. Ambassador Yin pointed out that the Cardiology Department project is a powerful testament to the friendship between the two peoples, a concrete manifestation of China's policy towards Africa characterized by "sincerity, real results, amity and good faith", and a positive outcome of implementing the consensus reached by the leaders of the two countries at the Forum on China-Africa Cooperation (FOCAC) Beijing Summit. China, ambassador Yin affirmed, will continue to support the development of Liberia's health sector and promote Liberia's ARREST Agenda for Inclusive Development. Distributed by APO Group on behalf of Embassy of the People's Republic of China in the Republic of Liberia.
Yahoo
01-06-2025
- Health
- Yahoo
Adding This Leafy Green to Lunch Lowers Systolic Levels Fast, According to Cardiologists
Adding This Leafy Green to Lunch Lowers Systolic Levels Fast, According to Cardiologists originally appeared on Parade. A small tweak to your lunch routine may do wonders for your heart health thanks to its impact on your systolic blood pressure.A study published in Nutrients reported that dark, leafy greens like arugula, cabbage, chard, kale and spinach that are high in vitamins, minerals are amazing for your blood pressure. But there's one that cardiologists love the most when it comes to nutritional value and cardiovascular health benefits, particularly on systolic blood pressure.A quick refresher on blood pressure readings in case you need it: Your systolic pressure is the upper number on your blood pressure reading, which the American Heart Association explains is the measurement of the pressure of your blood pushing against your arterial walls when your heart beats. The bottom number is your diastolic blood pressure, which is the pressure your blood puts on the walls of your arteries when your heart is at rest in between out the best leafy green to toss in your lunch bag for a seriously big boost to your precious ticker.🩺SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week💊 Shoutout to our boy Popeye: It's spinach! "Spinach may help lower systolic blood pressure, largely due to its rich content of dietary nitrates," Dr. Deepak Talreja, MD, cardiologist and clinical chief of cardiology at Sentara Health, tells Parade. "When we eat nitrate-rich foods like spinach, the body converts nitrates to nitric oxide, a molecule that relaxes and dilates blood vessels."When your blood vessels are dilated and relaxed, Dr. Talreja explains, your blood flow improves and your vascular resistance, which is the resistance against blood flowing through your veins and arteries."This can lead to a modest reduction in systolic blood pressure," he also points out that multiple studies support the impact of spinach on systolic blood pressure, singling out one in particular. "A randomized crossover trial published inHypertension found that a diet high in nitrate-rich vegetables such as spinach significantly reduced both systolic and diastolic blood pressure in hypertensive patients, particularly when consumed regularly," he says. "The effect may be seen within hours of consumption and can persist with daily intake." That said, if you're on medication for any cardiovascular issue, spinach isn't a substitute for that! But in most cases, it absolutely can be a huge boon to your health. "Regularly incorporating fresh spinach into meals—whether in salads, smoothies or sautés—can be a simple, natural way to support healthier blood pressure and overall cardiovascular wellbeing," Dr. Talreja says. "While spinach alone won't replace medications or other proven treatments, it can be part of a broader dietary strategy aligned with the DASH (Dietary Approaches to Stop Hypertension) and Mediterranean diets—both of which are associated with lower cardiovascular risk."Related: Whether You're Dealing With High Blood Pressure or Want to Avoid It in the Future, Here Are the 25 Best Foods to Eat There are so many—there's a reason it's most cardiologists' favorite food for protecting your arteries. According to Dr. Talreja, these are the main other ways spinach can contribute to your cardiovascular health. "Spinach is high in potassium, which helps counterbalance sodium in the diet and supports healthy blood pressure regulation," Dr. Talreja says. Related: The One Habit That Can Lower Your Blood Pressure Overnight, According to a Cardiologist "Adequate magnesium intake is associated with improved endothelial function and reduced risk of arrhythmias," he tells us. (Endothelial function means how well the thin inner lining of cells in your blood vessels work.) Antioxidants are so good for you in so many ways. Dr. Talreja says that spinach is particularly high in vitamin C, vitamin E and beta-carotene, all of which can reduce oxidative stress. Oxidative stress, in turn, can contribute to atherosclerosis (arteries clogged with cholesterol, fats and other substances) and vascular inflammation (damaged blood vessels).Related: "Folate is a B-vitamin helps lower homocysteine levels, which are linked to endothelial dysfunction and cardiovascular risk," Dr. Talreja explains. Dr. Talreja says this means it's great for weight control, blood sugar regulation and lipid management. You'll feel fuller longer when you eat it, which can also help prevent you from succumbing to cravings for less healthy snacks. Up Next:"Understanding Blood Pressure Readings." American Heart Association. Kapil, et. al. "Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study." Hypertension. Dr. Deepak Talreja, MD Adding This Leafy Green to Lunch Lowers Systolic Levels Fast, According to Cardiologists first appeared on Parade on May 31, 2025 This story was originally reported by Parade on May 31, 2025, where it first appeared.
